|
1
|
Dunnewind T, Dvortsin EP, Smeets HM,
Konijn RM, Bos JHJ, de Boer PT, van den Bergh JP and Postma MJ:
Economic consequences and potentially preventable costs related to
osteoporosis in the Netherlands. Value Health. 20:762–768. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ensrud KE and Crandall CJ: Osteoporosis.
Ann Intern Med. 168:306–307. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
McClung MR: Denosumab for the treatment of
osteoporosis. Osteoporos Sarcopenia. 3:8–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukumoto S and Matsumoto T: Recent
advances in the management of osteoporosis. F1000Res. 6:6252017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qaseem A, Forciea MA, McLean RM and
Denberg TD; Clinical Guidelines Committee of the American College
of Physicians. Treatment of low bone density or osteoporosis to
prevent fractures in men and women: A clinical practice guideline
update from the American college of physicians. Ann Intern Med.
166:818–839. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hernlund E, Svedbom A, Ivergård M,
Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B and Kanis
JA: Osteoporosis in the European Union: Medical management,
epidemiology and economic burden. A report prepared in
collaboration with the International Osteoporosis Foundation (IOF)
and the European Federation of Pharmaceutical Industry Associations
(EFPIA). Arch Osteoporos. 8:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramírez J, Nieto-González JC, Curbelo
Rodríguez R, Castañeda S and Carmona L: Prevalence and risk factors
for osteoporosis and fractures in axial spondyloarthritis: A
systematic review and meta-analysis. Semin Arthritis Rheum.
48:44–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tawaratsumida H, Setoguchi T, Arishima Y,
Ohtsubo H, Akimoto M, Ishidou Y, Nagano S, Taketomi E, Sunahara N
and Komiya S: Risk factors for bone loss in patients with
rheumatoid arthritis treated with biologic disease-modifying
anti-rheumatic drugs. BMC Res Notes. 10:7652017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Minisola S, Cipriani C, Occhiuto M and
Pepe J: New anabolic therapies for osteoporosis. Intern Emerg Med.
12:915–921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rossini M, Adami S, Bertoldo F, Diacinti
D, Gatti D, Giannini S, Giusti A, Malavolta N, Minisola S, Osella
G, et al: Guidelines for the diagnosis, prevention and management
of osteoporosis. Reumatismo. 68:1–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanis JA, Cooper C, Rizzoli R and
Reginster JY; Scientific Advisory Board of the European Society for
Clinical and Economic Aspects of Osteoporosis (ESCEO) and the
Committees of Scientific Advisors and National Societies of the
International Osteoporosis Foundation (IOF). European guidance for
the diagnosis and management of osteoporosis in postmenopausal
women. Osteoporos Int. 30:3–44. 2019. View Article : Google Scholar
|
|
12
|
Management of osteoporosis in
postmenopausal women: 2010 position statement of the North American
Menopause Society. Menopause. 17:25–54; quiz 55–26. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai L, Wu H, Yu S, Zhao H, Xue L, Xu M,
Shen Z and Hu M: Effects of OsteoKing on osteoporotic rabbits. Mol
Med Rep. 12:1066–1074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan L, Ma J, Chen Y and Chen X:
Antioxidant and antimicrobial phenolic compounds from Setaria
viridis. Chem Nat Compounds. 50:433–437. 2014. View Article : Google Scholar
|
|
15
|
Hu M, Zhao HB, Qian CY, et al:
Ultrastructural evaluation of the SANFH rabbit animal models
intervened by Osteoking. Chin J Tradit Chin Med Pharm. 26:486–489.
2011.(In Chinese).
|
|
16
|
Zhao HB, Hu M and Liang HS: Experimental
study on osteoking in promoting gene expression of core binding
factor alpha 1 in necrotic femoral head of rabbits. Zhongguo Zhong
Xi Yi Jie He Za Zhi. 26:1003–1006. 2006.(In Chinese). PubMed/NCBI
|
|
17
|
Zhao H, Hu M, Wang W and Li L: Effects of
the VEGF gene expressions of Osteoking in the treatment of femoral
head necrosis. China J Orthop Traumatol. 20:757–759. 2007.
|
|
18
|
Zhao HB, Hu M, Zheng HY, Liang HS and Zhu
XS: Clinical study on effect of Osteoking in preventing
postoperational deep venous thrombosis in patients with
intertrochanteric fracture. Chin J Integr Med. 22:297–299.
2005.
|
|
19
|
Yan S: The effect of Osteoking on
ovariectomized female rat model of Osteoporosis in Chinese. Chin J
Osteoporosis. 12:21–24. 2016.
|
|
20
|
Hu M, Zhao HB, Wang B, Liang HS, Zhang CQ,
Zheng HY and Zhao XL: Clinical observation on promoting effect of
henggu gushang union agent on post-operational healing of
Gosselin’s fracture. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2:160–161.
2005.(In Chinese).
|
|
21
|
Hasan S, Bonde BK, Buchan NS and Hall MD:
Network analysis has diverse roles in drug discovery. Drug Discov
Today. 17:869–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Keiser MJ, Setola V, Irwin JJ, Laggner C,
Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, et
al: Predicting new molecular targets for known drugs. Nature.
462:175–181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin D, Zhang H, Zhang H, Sun T, Zhao H and
Lee WH: Anti-osteoporosis effects of osteoking via reducing
reactive oxygen species. J Ethnopharmacol. 244:1120452019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jones-Bolin S: Guidelines for the care and
use of laboratory animals in biomedical research. Curr Protoc
Pharmacol. Appendix 4: Appendix 4B. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahlquist RP: Experimental methods in
pharmacology. J Pharm Sci. 59:7282010. View Article : Google Scholar
|
|
26
|
Morgan SL and Prater GL: Quality in
dual-energy X-ray absorptiometry scans. Bone. 104:13–28. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clough E and Barrett T: The gene
expression omnibus database. Methods Mol Biol. 1418:93–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gage GJ, Kipke DR and Shain W: Whole
animal perfusion fixation for rodents. J Vis Exp.
35642012.PubMed/NCBI
|
|
29
|
Bouxsein ML, Boyd SK, Christiansen BA,
Guldberg RE, Jepsen KJ and Müller R: Guidelines for assessment of
bone microstructure in rodents using micro-computed tomography. J
Bone Miner Res. 25:1468–1486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
The UniProt Consortium. The universal
protein knowledgebase. Nucleic Acids Res. 45:D158–D169. 2017.
View Article : Google Scholar
|
|
31
|
NCBI Resource Coordinators. Database
resources of the National Center for Biotechnology Information.
Nucleic Acids Res. 46:D8–D13. 2018. View Article : Google Scholar :
|
|
32
|
Kibbe WA: OligoCalc: An online
oligonucleotide properties calculator. Nucleic Acids Res. 35(Web
Server issue): W43–W46. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
34
|
Guo XL, Liu LZ, Wang QQ, Liang JY, Lee WH,
Xiang Y, Li SA and Zhang Y: Endogenous pore-forming protein complex
targets acidic glycosphingolipids in lipid rafts to initiate
endolysosome regulation. Commun Biol. 2:592019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zuehlke AD, Moses MA and Neckers L: Heat
shock protein 90: Its inhibition and function. Philos Trans R Soc
Lond B Biol Sci. 373:201605272018. View Article : Google Scholar
|
|
36
|
Yan X, Hui Y, Hua Y, Huang L, Wang L, Peng
F, Tang C, Liu D, Song J and Wang F: EG-VEGF silencing inhibits
cell proliferation and promotes cell apoptosis in pancreatic
carcinoma via PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother.
109:762–769. 2019. View Article : Google Scholar
|
|
37
|
Saryeddine L, Zibara K, Kassem N, Badran B
and El-Zein N: EGF-induced VEGF exerts a PI3K-dependent positive
feedback on ERK and AKT through VEGFR2 in hematological in vitro
models. PLoS One. 11:e01658762016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yasui H, Hideshima T, Ikeda H, Jin J, Ocio
EM, Kiziltepe T, Okawa Y, Vallet S, Podar K, Ishitsuka K, et al:
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock
protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38
mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma
cell lines and inhibits paracrine tumour growth. Br J Haematol.
136:414–423. 2007. View Article : Google Scholar
|
|
39
|
Khong T and Spencer A: Targeting HSP90
induces apoptosis and inhibits critical survival and proliferation
pathways in multiple myeloma. Mol Cancer Ther. 10:1909–1917. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Miyasaka M, Nakata H, Hao J, Kim YK,
Kasugai S and Kuroda S: Low-intensity pulsed ultrasound stimulation
enhances heat-shock protein 90 and mineralized nodule formation in
mouse calvaria-derived osteoblasts. Tissue Eng Part A.
21:2829–2839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tash JS, Chakrasali R, Jakkaraj SR, Hughes
J, Smith SK, Hornbaker K, Heckert LL, Ozturk SB, Hadden MK, Kinzy
TG, et al: Gamendazole, an orally active indazole carboxylic acid
male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1
(eEF1A), and stimulates Il1a transcription in rat Sertoli cells.
Biol Reprod. 78:1139–1152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yao Y, Watson AD, Ji S and Bostrom KI:
Heat shock protein 70 enhances vascular bone morphogenetic
protein-4 signaling by binding matrix Gla protein. Circ Res.
105:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Z, Ma Y, Guo S, He Y, Bai G and
Zhang W: Low-intensity pulsed ultrasound stimulation facilitates in
vitro osteogenic differentiation of human adipose-derived stem
cells via up-regulation of heat shock protein (HSP)70, HSP90, and
bone morphogenetic protein (BMP) signaling pathway. Biosci Rep.
38:BSR201800872018. View Article : Google Scholar :
|
|
44
|
Chung E, Sampson AC and Rylander MN:
Influence of heating and cyclic tension on the induction of heat
shock proteins and bone-related proteins by MC3T3-E1 cells. Biomed
Res Int. 2014:354260. 2014. View Article : Google Scholar
|
|
45
|
Graner MW: HSP90 and immune modulation in
cancer. Adv Cancer Res. 129:191–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Vázquez-Carrera M: HSP90 inhibitors as a
future therapeutic strategy in diabetes-driven atherosclerosis.
Clin Investig Arterioscler. 29:67–68. 2017.(In English, Spanish).
PubMed/NCBI
|
|
47
|
Yu C, Dai L, Ma Z, Zhao H, Yuan Y, Zhang
Y, Bao P, Su Y, Ma D, Liu C, et al: Effect of Osteoking on the
osteogenic and adipogenic differentiation potential of rat bone
marrow mesenchymal stem cells in vitro. BMC Complement Altern Med.
19:362019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang K, Wu G, Zou J and Peng S:
Combination therapy with BMP-2 and psoralen enhances fracture
healing in ovariectomized mice. Exp Ther Med. 16:1655–1662.
2018.PubMed/NCBI
|
|
49
|
Griffith JF, Wang YX, Zhou H, Kwong WH,
Wong WT, Sun YL, Huang Y, Yeung DK, Qin L and Ahuja AT: Reduced
bone perfusion in osteoporosis: Likely causes in an ovariectomy rat
model. Radiology. 254:739–746. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ding WG, Wei ZX and Liu JB: Reduced local
blood supply to the tibial metaphysis is associated with
ovariectomy-induced osteoporosis in mice. Connect Tissue Res.
52:25–29. 2011. View Article : Google Scholar
|
|
51
|
Peng J, Lai ZG, Fang ZL, Xing S, Hui K,
Hao C, Jin Q, Qi Z, Shen WJ, Dong QN, et al: Dimethyloxalylglycine
prevents bone loss in ovariectomized C57BL/6J mice through enhanced
angiogenesis and osteogenesis. PLoS One. 9:e1127442014. View Article : Google Scholar : PubMed/NCBI
|
